Attenuation of Nitrogen Mustard-Induced Pulmonary Injury and Fibrosis by Anti-Tumor Necrosis Factor-α Antibody

被引:50
|
作者
Malaviya, Rama [1 ]
Sunil, Vasanthi R. [1 ]
Venosa, Alessandro [1 ]
Verissimo, Vivianne L. [1 ]
Cervelli, Jessica A. [1 ]
Vayas, Kinal N. [1 ]
Hall, LeRoy [3 ]
Laskin, Jeffrey D. [2 ]
Laskin, Debra L. [1 ]
机构
[1] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Dept Environm & Occupat Med, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA
[3] Janssen Res & Dev, Dept Drug Safety Sci, Raritan, NJ 08869 USA
基金
美国国家卫生研究院;
关键词
alveolar macrophages; lung injury; vesicant; fibrosis; ACUTE LUNG INJURY; SULFUR MUSTARD; MACROPHAGE ACTIVATION; TISSUE-INJURY; MURINE MODEL; TNF-ALPHA; INFLAMMATION; EXPRESSION; MECHANISMS; RECEPTOR;
D O I
10.1093/toxsci/kfv161
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Nitrogen mustard (NM) is a bifunctional alkylating agent that causes acute injury to the lung that progresses to fibrosis. This is accompanied by a prominent infiltration of macrophages into the lung and upregulation of proinflammatory/profibrotic cytokines including tumor necrosis factor (TNF)alpha. In these studies, we analyzed the ability of anti-TNF alpha antibody to mitigate NM-induced lung injury, inflammation, and fibrosis. Treatment of rats with anti-TNF alpha antibody (15 mg/kg, iv, every 9 days) beginning 30 min after intratracheal administration of NM (0.125 mg/kg) reduced progressive histopathologic alterations in the lung including perivascular and peribronchial edema, macrophage/monocyte infiltration, interstitial thickening, bronchiolization of alveolar walls, fibrin deposition, emphysema, and fibrosis. NM-induced damage to the alveolar-epithelial barrier, measured by bronchoalveolar lavage (BAL) protein and cell content, was also reduced by anti-TNF alpha antibody, along with expression of the oxidative stress marker, heme oxygenase-1. Whereas the accumulation of proinflammatory/cytotoxic M1 macrophages in the lung in response to NM was suppressed by anti-TNF alpha antibody, antiinflammatory/profibrotic M2 macrophages were increased or unchanged. Treatment of rats with anti-TNF alpha antibody also reduced NM-induced increases in expression of the profibrotic mediator, transforming growth factor-beta. This was associated with a reduction in NM-induced collagen deposition in the lung. These data suggest that inhibiting TNF alpha may represent an efficacious approach to mitigating lung injury induced by mustards.
引用
收藏
页码:71 / 88
页数:18
相关论文
共 50 条
  • [41] Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis
    Tilg, H
    Jalan, R
    Kaser, A
    Davies, NA
    Offner, FA
    Hodges, SJ
    Ludwiczek, O
    Shawcross, D
    Zoller, H
    Alisa, A
    Mookerjee, RP
    Graziadei, N
    Datz, C
    Trauner, M
    Schuppan, D
    Obrist, P
    Vogel, W
    Williams, R
    JOURNAL OF HEPATOLOGY, 2003, 38 (04) : 419 - 425
  • [42] Anti-Tumor Necrosis Factor α Prevents Bowel Fibrosis Assessed by Messenger RNA, Histology, and Magnetization Transfer MRI in Rats With Crohn's Disease
    Adler, Jeremy
    Rahal, Kinan
    Swanson, Scott D.
    Schmiedlin-Ren, Phyllissa
    Rittershaus, Ahren C.
    Reingold, Laura J.
    Brudi, Josh S.
    Shealy, David
    Cai, Ann
    McKenna, Barbara J.
    Zimmermann, Ellen M.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (04) : 683 - 690
  • [43] Tumor Necrosis Factor-α Plays an Initiating Role in Extracorporeal Circulation-induced Acute Lung Injury
    Tao Li
    Nanfu Luo
    Lei Du
    Jing Zhou
    Jie Zhang
    Lina Gong
    Nenggang Jiang
    Lung, 2013, 191 : 207 - 214
  • [44] The CD4+ Lymphopenic Sarcoidosis Phenotype Is Highly Responsive to Anti-Tumor Necrosis Factor-α Therapy
    Crouser, Elliott D.
    Lozanski, Gerard
    Fox, Charity C.
    Hauswirth, David W.
    Raveendran, Rekha
    Julian, Mark W.
    CHEST, 2010, 137 (06) : 1432 - 1435
  • [45] To explore the influencing factors of clinical failure of anti-tumor necrosis factor-α (TNF-α) therapy in sepsis
    Zhou, Yonghong
    Yu, Zhaoran
    Lu, Yiming
    LIFE SCIENCES, 2025, 369
  • [46] Anti-Tumor Necrosis Factor-α Antibodies Induce Regulatory Macrophages in an Fc Region-Dependent Manner
    Vos, Anne Christine W.
    Wildenberg, Manon E.
    Duijvestein, Marjolijn
    Verhaar, Auke P.
    van den Brink, Gijs R.
    Hommes, Daniel W.
    GASTROENTEROLOGY, 2011, 140 (01) : 221 - +
  • [47] Inflammatory Profile and Response to Anti-Tumor Necrosis Factor Therapy in Patients with Chronic Pulmonary Sarcoidosis
    Loza, Matthew J.
    Brodmerkel, Carrie
    Du Bois, Roland M.
    Judson, Marc A.
    Costabel, Ulrich
    Drent, Marjolein
    Kavuru, Mani
    Flavin, Susan
    Lo, Kim Hung
    Barnathan, Elliot S.
    Baughman, Robert P.
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (06) : 931 - 939
  • [48] Therapeutic hypercapnia prevents bleomycin-induced pulmonary hypertension in neonatal rats by limiting macrophage-derived tumor necrosis factor-α
    Sewing, A. Charlotte P.
    Kantores, Crystal
    Ivanovska, Julijana
    Lee, Alvin H.
    Masood, Azhar
    Jain, Amish
    McNamara, Patrick J.
    Tanswell, A. Keith
    Jankov, Robert P.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2012, 303 (01) : L75 - L87
  • [49] Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model
    Chiorazzi, Alessia
    Canta, Annalisa
    Meregalli, Cristina
    Carozzi, Valentina
    Sala, Barbara
    Oggioni, Norberto
    Monbaliu, Johan
    Van de Velde, Helgi
    Cavaletti, Guido
    ANTICANCER RESEARCH, 2013, 33 (12) : 5453 - 5459
  • [50] Simvastatin inhibits ischemia/reperfusion injury-induced apoptosis of retinal cells via downregulation of the tumor necrosis factor-α/nuclear factor-κB pathway
    Zhang, Yu
    Zhang, Zhuhong
    Yan, Hua
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 (02) : 399 - 405